Let Me Trial
PrivateCompany Overview
Let Me Trial is a healthtech company that provides a science-based digital health platform for mapping and curating clinical trials in oncology and onco-haematology.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Let Me Trial Comparables
Compare Let Me Trial with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LifeTime Clinical Research | 88% | |
| laví | 84% | |
| Ancora.ai | 77% |
Let Me Trial Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Grew 60% QoQ, from 5 to 8 employees.
Let Me Trial Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Let Me Trial's valuation, stock price, and market status.
Is Let Me Trial a public or private company?
Let Me Trial is a private company.
What is the current stock price of Let Me Trial?
Let Me Trial is a private company with no public stock price. Caplight tracks Let Me Trial's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Let Me Trial worth (valuation)?
Valuation information for Let Me Trial is not publicly available.
Can I buy Let Me Trial stock?
Let Me Trial shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Let Me Trial's last funding round?
Funding round information for Let Me Trial is not publicly available.
Who are the main investors in Let Me Trial?
Investor information for Let Me Trial is not publicly disclosed.
Will Let Me Trial IPO soon?
No public IPO plans have been announced for Let Me Trial.
How can I track Let Me Trial secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Let Me Trial's secondary market activity and sign up for updates.